MBX Biosciences, Inc. (NYSE:MBX) Receives $37.50 Consensus PT from Brokerages
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received an average recommendation of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have covered the stock in the […]
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have received an average recommendation of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have covered the stock in the […]
